Executives

4

Insilico Medicine Management Team

4 Team Members

Insilico Medicine has 4 executives. Insilico Medicine's current Founder, Chief Executive Officer is Alex Zhavoronkov.

Name

Work History

Title

Status

Alex Zhavoronkov

Sequenom, and Colby Pharmaceutical Company

Founder, Chief Executive Officer

Current

Alex Aliper

President

Current

Qingsong Zhu

Chief Operating Officer

Former

Alex Zhebrak

Mail.ru Group

Chief Technology Officer

Former

Name

Alex Zhavoronkov

Alex Aliper

Qingsong Zhu

Alex Zhebrak

Work History

Sequenom, and Colby Pharmaceutical Company

Mail.ru Group

Title

Founder, Chief Executive Officer

President

Chief Operating Officer

Chief Technology Officer

Status

Current

Current

Former

Former

You May Also Like

Atomwise Logo
Atomwise

Atomwise uses deep learning neural networks to help discover new medicines. Atomwise achieves results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, start-ups, and research institutions. It is currently using computational drug design to design drugs against COVID.

insitro Logo
insitro

insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients.

Cyclica Logo
Cyclica

Cyclica is a global biotechnology company that leverages artificial intelligence and computational biophysics to reshape the drug discovery process. Cyclica's structure-based and AI-augmented drug discovery platform includes Ligand Design for multi-targeted and multi-objective drug design, and Ligand Express for off-target profiling, systems biology linkages, and structural pharmacogenomic insights.

GNS Healthcare Logo
GNS Healthcare

GNS Healthcare applies artificial intelligence (AI) platform to unravel the complexity of human disease in order to match the right treatment to the right patient at the right time.

Healx Logo
Healx

Healx is an AI-powered and patient-inspired technology company, accelerating the discovery and development of rare disease treatments. Its AI drug discovery platform leverages public and proprietary biomedical data and features a knowledge graph for rare diseases.

Aria Pharmaceuticals Logo
Aria Pharmaceuticals

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company that discovers and develops novel small molecule therapies for complex and hard-to-treat diseases

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.